Hans Haag

Dec 3, 2023 | bcmj.org | Daniel Hong |Hans Haag |Anthony Lau

The baseline risk of symptomatic venous thromboembolism (VTE) in the first 35 days after major orthopaedic surgery has been estimated at 4.3%.[1] This burden of VTE, along with a much higher incidence of asymptomatic cases and potential complications, is the basis for the numerous clinical trials that have investigated pharmaceutical options for thromboprophylaxis in this patient population, including antiplatelet agents such as ASA and anticoagulants such as vitamin K antagonists,...